Cisplatin and novobiocin in the treatment of non-small cell lung cancer. A southwest oncology group study
- 15 June 1991
- Vol. 67 (12) , 2969-2973
- https://doi.org/10.1002/1097-0142(19910615)67:12<2969::aid-cncr2820671205>3.0.co;2-m
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Cisplatin Dose Intensity in Non-Small Cell Lung Cancer: Phase II Results of a Day 1 and Day 8 High-Dose RegimenJNCI Journal of the National Cancer Institute, 1989
- Elevated DNA topoisomerase II activity in nitrogen mustard-resistant human cells.Proceedings of the National Academy of Sciences, 1987
- Novobiocin enhances alkylating agent cytotoxicity and DNA interstrand crosslinks in a murine model.Journal of Clinical Investigation, 1987
- Steady-state serum pharmacokinetics of novobiocin and rifampin alone and in combinationAntimicrobial Agents and Chemotherapy, 1986
- Efficacy study of intensive cis-platin therapy in advanced non-small cell bronchogenic carcinomaCancer, 1982
- High-Performance liquid chromatogrphic method for the determination of novobiocinJournal of Chromatography A, 1982